 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/301776
The Pharmaceutical Market: Lithuania
|
Description: |
THE PHARMACEUTICAL MARKET: LITHUANIA - REVIEW
The Lithuanian economy decreased considerably in 2009 but the economy is now recovering and a small level of growth is expected in 2011, as private consumption and investment spending increases. Health expenditure growth will remain steady, increasing by a moderate CAGR between 2011 and 2016. The country currently spends a proportion of GDP on healthcare similar to Bulgaria and Hungary. Nearly three-quarters of expenditure is in the public sector, and since 1997, this has been almost entirely through the Compulsory Health Insurance Fund. Politically, the Lithuanian government has lost its majority in parliament as a number of members have moved to the opposition. The economy minister resigned in March 2011 and a further loss of ministers could lead to the formation of a new coalition.
The health of Lithuanians continues to be generally poor, as elsewhere in the former USSR. Poor diet, high levels of smoking and alcoholism and low awareness of health issues have led to high levels of morbidity and a relatively low life expectancy, especially for men. According to the Lithuanian Health Information Centre, alcohol abuse remains a significant problem, although the number of deaths from alcohol-related causes is starting to decrease. The government estimates that there are over 500,000 actual or potential alcoholics, resulting in a high incidence of alcohol-related illness, deaths from alcohol poisoning, and suicides. Circulatory diseases and cancer are the leading causes of death.
Lithuania has a small yet expanding pharmaceutical market, with a strong generic sector. In 2011, the Lithuanian pharmaceutical market is comparable in size to Serbia and similar to Poland in per capita terms. The market is expected to expand at a moderate CAGR over the next few years; in per capita terms, spending will be above the regional average in 2016. The country was hit particularly hard by the global economic crisis, but growth in the Lithuanian pharmaceutical market will pick up as the economy continues to recover and imports strengthen. A large proportion of the market is supplied by imports, principally from other European countries. Generics represent around two thirds of the market in terms of volume. Sales of generics could increase in the future if the government goes ahead with plans to make generic drugs at least 30% cheaper than their branded equivalents.
ENHANCED STRATEGIC INTELLIGENCE
These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
- Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. - Specialised intelligence on OTCs, generics, biologics and biosimilars. - Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series. - A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel. - The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
HEALTHCARE STATISTICS
A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included. |
|
Contents: |
HEALTHCARE STATISTICS
A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.
EXECUTIVE SUMMARY Including Espicom's at a glance strategic analysis and key data projections
MACROENVIRONMENT Political, economic, legal and demographic analysis
EPIDEMIOLOGY Disease burden and prevalence
HEALTHCARE Organisation, expenditure, infrastructure, services and workforce
REGULATORY AFFAIRS Regulatory developments and marketing registration/authorisation
PRICING & REIMBURSEMENT
DISTRIBUTION CHANNELS
MARKET ANALYSIS Projections, product development, manufacturing and trade
COMPETITION Trade associations, trade fairs, company intelligence and competitive strategies
OTC PHARMACEUTICALS
GENERIC PHARMACEUTICALS
BIOLOGICS & BIOSIMILARS
OPPORTUNITIES & CHALLENGES Espicom's unique strategic analysis
DIRECTORY
METHODOLOGY & SOURCES |
|
Companies Mentioned |
Domestic Producers include:
- Sanitas |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/301776
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 13/02/2012 08:06:52 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
The Pharmaceutical Market: Lithuania
|
|
Web Address: |
http://www.researchandmarkets.com/reports/301776
|
|
Office Code: |
|
OC8IHINLSNNSS
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (Online Access)
- Enterprisewide
|
|
€5,050.00
|
|
Electronic (PDF)
- Enterprisewide
|
|
€5,050.00
|
|
Electronic (Online Access)
- Single User
|
|
€775.00
|
|
Hard Copy
|
|
€775.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic (PDF)
- Single User
|
|
€775.00
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 13/02/2012 08:06:52
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|